CMKLR1 and graft versus host disease: As expected, t-KO mice developed more severe GvHD compared with t-WT mice, and the administration of monocytes from Cmklr1-KO mice (t-KO+KO monocytes) did not change the phenotype in terms of either survival or GvHD clinical score.